Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Abizaid

Showing results (181-190 of 306) with videos related to

Pageof 31
Sort By:
European Heart Journal|December 20, 2003
Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesionsMuzaffer Degertekin, Pedro A Lemos, Chi Hang Lee, et al.
Journal of the American College of Cardiology|July 19, 2005
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)Patrick W Serruys, Georgios Sianos, Alexandre Abizaid, et al.
European Heart Journal|January 15, 2004
Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL TrialAlexandre Abizaid, Marco A Costa, Didier Blanchard, et al.
JACC. Cardiovascular Interventions|November 21, 2015
Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)Yuki Ishibashi, Shimpei Nakatani, Yohei Sotomi, et al.
Lancet (London, England)|October 17, 2015
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trialMichael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
Circulation|January 8, 2003
Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound studyJ Eduardo Sousa, Marco A Costa, Alexandre Abizaid, et al.
European Heart Journal. Cardiovascular Imaging|December 28, 2018
Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions: an optical coherence tomography analysisYuichi Ozaki, Hector M Garcia-Garcia, Alexandre Hideo-Kajita, et al.
JACC. Cardiovascular Interventions|March 26, 2016
Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary LesionsAlexandre Abizaid, Ricardo A Costa, Joachim Schofer, et al.
The American Journal of Cardiology|May 12, 2007
Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stentAlexandre Abizaid, Alexandra J Lansky, Peter J Fitzgerald, et al.
The International Journal of Cardiovascular Imaging|November 18, 2010
Serial angiographic and intravascular ultrasound evaluation to interrogate the presence of late "catch-up" phenomenon after Cypher® sirolimus-eluting stent implantationDaniel Chamié, Alexandre Abizaid, J Ribamar Costa, et al.
Pageof 31

Showing results (181-190 of 306) with videos related to

Sort By:
Pageof 31
European Heart Journal|December 20, 2003
Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesionsMuzaffer Degertekin, Pedro A Lemos, Chi Hang Lee, et al.
Journal of the American College of Cardiology|July 19, 2005
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)Patrick W Serruys, Georgios Sianos, Alexandre Abizaid, et al.
European Heart Journal|January 15, 2004
Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL TrialAlexandre Abizaid, Marco A Costa, Didier Blanchard, et al.
JACC. Cardiovascular Interventions|November 21, 2015
Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)Yuki Ishibashi, Shimpei Nakatani, Yohei Sotomi, et al.
Lancet (London, England)|October 17, 2015
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trialMichael Haude, Hüseyin Ince, Alexandre Abizaid, et al.
Circulation|January 8, 2003
Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound studyJ Eduardo Sousa, Marco A Costa, Alexandre Abizaid, et al.
European Heart Journal. Cardiovascular Imaging|December 28, 2018
Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions: an optical coherence tomography analysisYuichi Ozaki, Hector M Garcia-Garcia, Alexandre Hideo-Kajita, et al.
JACC. Cardiovascular Interventions|March 26, 2016
Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary LesionsAlexandre Abizaid, Ricardo A Costa, Joachim Schofer, et al.
The American Journal of Cardiology|May 12, 2007
Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stentAlexandre Abizaid, Alexandra J Lansky, Peter J Fitzgerald, et al.
The International Journal of Cardiovascular Imaging|November 18, 2010
Serial angiographic and intravascular ultrasound evaluation to interrogate the presence of late "catch-up" phenomenon after Cypher® sirolimus-eluting stent implantationDaniel Chamié, Alexandre Abizaid, J Ribamar Costa, et al.
Pageof 31